Fen Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fen Ye has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Hao Cheng
5 shared publicationsChao Chen
Jiangxi Key Laboratory of Advanced Ceramic Materials, Department of Material Science and Engineering, Jingdezhen Ceramic University, Jingdezhen, China
3 shared publicationsRenfen Zeng
Jiangxi Key Laboratory of Advanced Ceramic Materials, Department of Material Science and Engineering, Jingdezhen Ceramic University, Jingdezhen, China
3 shared publicationsXiaokun Huang
Jiangxi Key Laboratory of Advanced Ceramic Materials, Department of Material Science and Engineering, Jingdezhen Ceramic University, Jingdezhen, China
3 shared publicationsXin Nie
Jiangxi Key Laboratory of Advanced Ceramic Materials, Department of Material Science and Engineering, Jingdezhen Ceramic University, Jingdezhen, China
3 shared publications- Hao Cheng
School of Mechanical and Electronic Engineering, Jingdezhen University, Jingdezhen 333403, China
2 shared publications
Latest Publications
- Open Access
Preparation of NaNbO3-Based Piezocatalysts via Solid-State Method and Piezocatalytic Degradation of Organic Pollutants
Piezoelectric catalysis exploits the piezoelectric effect of materials under mechanical stress, inducing surface charges that participate in wastewater degradation reactions. This process generates no secondary pollution and represents an environmentally friendly, novel degradation technique. In this work, (0.92 − x)NaNbO3–0.08BaTiO3–xBiFeO3 piezoelectric powders were synthesized via a solid-state method. Ultrasonic waves were employed as the mechanical driving force, and the degradation of organic pollutants by piezoelectric catalysis was investigated. The results show that the NN-based powders and ceramics exhibit multiphase structures. The degradation efficiency of Rhodamine B (RhB) reached 88.11% within 80 min. Upon application of an external magnetic field, the degradation rate was enhanced. Furthermore, the piezoelectric catalytic powder demonstrated excellent cycling stability. Active species trapping experiments identified •OH and •O2− as the dominant reactive species. Instead of the conventional approach of preparing piezoelectric ceramics followed by crushing, this study directly produces NaNbO3-based piezoelectric powders using a solid-state method. The applied magnetic field may assist charge separation during piezocatalysis, offering a new route for the piezoelectric catalytic degradation of organic compounds.
Open AccessPreparation of NaNbO3-Based Piezocatalysts via Solid-State Method and Piezocatalytic Degradation of Organic Pollutants
Piezoelectric catalysis exploits the piezoelectric effect of materials under mechanical stress, inducing surface charges that participate in wastewater degradation reactions. This process generates no secondary pollution and represents an environmentally friendly, novel degradation technique. In this work, (0.92 − x)NaNbO3–0.08BaTiO3–xBiFeO3 piezoelectric powders were synthesized via a solid-state method. Ultrasonic waves were employed as the mechanical driving force, and the degradation of organic pollutants by piezoelectric catalysis was investigated. The results show that the NN-based powders and ceramics exhibit multiphase structures. The degradation efficiency of Rhodamine B (RhB) reached 88.11% within 80 min. Upon application of an external magnetic field, the degradation rate was enhanced. Furthermore, the piezoelectric catalytic powder demonstrated excellent cycling stability. Active species trapping experiments identified •OH and •O2− as the dominant reactive species. Instead of the conventional approach of preparing piezoelectric ceramics followed by crushing, this study directly produces NaNbO3-based piezoelectric powders using a solid-state method. The applied magnetic field may assist charge separation during piezocatalysis, offering a new route for the piezoelectric catalytic degradation of organic compounds.
- 31 August 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (22) , 46327-46333
Component design for stabilizing P phase in NaNbO3-based ceramics and the energy storage performance
- 31 August 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (22) , 46327-46333
Component design for stabilizing P phase in NaNbO3-based ceramics and the energy storage performance
- 29 June 2022
- Published by Elsevier in Ceramics International
- Vol. 48 (20) , 30325-30331
Effect of in situ synthesized and additives on the thermal performance of mullite thermal storage ceramics
- 29 June 2022
- Published by Elsevier in Ceramics International
- Vol. 48 (20) , 30325-30331
Effect of in situ synthesized and additives on the thermal performance of mullite thermal storage ceramics
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 4118
Abstract 4118: Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14)
Background: Treatment (Tx) options for METex14 NSCLC have been limited to chemotherapy (Ctx), immunotherapy (IO), and multikinase inhibitors (MKi) until FDA approvals of selective MET inhibitors (METi) from 2020. BM are a further challenge to treat. We previously reported NGS timing in relation to start of first-line Tx (1L) for pts with METex14 NSCLC in the RW. Here we provide overall survival (OS) data, including subgroup analyses for pts with known BM prior to 1L initiation. Methods: Data originating from ~280 US cancer clinics (~800 sites of care) from the US electronic health record-derived de-identified Flatiron Health Foundation Medicine clinico-genomic database (FH-FMI CGDB) were evaluated. Pts were ≥18 yrs, diagnosed with advanced/metastatic NSCLC from Jan 1, 2011, with NGS-confirmed METex14, ≥1 line of Tx, and ≥90 days follow-up from 1L initiation to cutoff date (Dec 2020). Pts treated with capmatinib or tepotinib were excluded. We examined Tx patterns and OS for pts with and without known BM before starting 1L, and OS for pts with an NGS report before or on/after 1L initiation (time from 1L initiation to death or censoring, analyzed using Kaplan-Meier method with left truncation adjustment to mitigate bias due to the prerequisite for NGS testing). HRs were estimated using Cox regression models with covariates adjustment to estimate risk of death. Results: The analysis included 156 METex14 NSCLC pts: median age 75 yrs, 59% females, 85.3% non-squamous (NSQ), 9% squamous cell carcinoma (SQ), and 64% had history of smoking. A total of 31 pts (20%) had BM before 1L initiation: median age 73 yrs, 61% females, 94% NSQ, 0% SQ, and 71% had history of smoking. Overall, treatment patterns were similar for pts with and without known BM before 1L initiation (Ctx with or without IO, IO monotherapy, and MKi were all used in 1L). Median OS for pts with BM was 8.11 mo (95% CI, 6.0-19.8) and 14.39 mo (11.1-22.1) for pts without BM, corresponding to a 73% increase in risk of death for pts with BM vs pts without BM by univariate analysis (HR 1.73 [95% CI, 1.06-2.82]; P=0.03). Median OS for pts with an NGS report before and on/after 1L initiation was 13.3 mo (8.8-26.2) and 6.8 mo (0.03-19.8), respectively (P=0.45); HR by multivariate analysis was 0.78 (0.45-1.35) when comparing pts with NGS report before vs on/after 1L initiation. Conclusions: Tx patterns in 1L were similar for pts with or without BM at time of 1L initiation; presence of BM prior to 1L was associated with inferior outcomes. Numerically longer OS was observed in pts with NGS report prior to 1L initiation vs pts with NGS report on/after 1L, supporting further investigation of underlying causes. These data underline the ongoing unmet clinical need of METex14 NSCLC BM and the importance of investigating upfront comprehensive genomic testing in NSCLC. Citation Format: Xiuning Le, Stephen Robb, Nydia Caro, Simona Doria, Whitney C. Rhodes, Wen-Hsing Wu, Julia Kim, Vincent Prêtre, Fen Ye. Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 4118.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 4118
Open AccessAbstract 4118: Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14)
Background: Treatment (Tx) options for METex14 NSCLC have been limited to chemotherapy (Ctx), immunotherapy (IO), and multikinase inhibitors (MKi) until FDA approvals of selective MET inhibitors (METi) from 2020. BM are a further challenge to treat. We previously reported NGS timing in relation to start of first-line Tx (1L) for pts with METex14 NSCLC in the RW. Here we provide overall survival (OS) data, including subgroup analyses for pts with known BM prior to 1L initiation. Methods: Data originating from ~280 US cancer clinics (~800 sites of care) from the US electronic health record-derived de-identified Flatiron Health Foundation Medicine clinico-genomic database (FH-FMI CGDB) were evaluated. Pts were ≥18 yrs, diagnosed with advanced/metastatic NSCLC from Jan 1, 2011, with NGS-confirmed METex14, ≥1 line of Tx, and ≥90 days follow-up from 1L initiation to cutoff date (Dec 2020). Pts treated with capmatinib or tepotinib were excluded. We examined Tx patterns and OS for pts with and without known BM before starting 1L, and OS for pts with an NGS report before or on/after 1L initiation (time from 1L initiation to death or censoring, analyzed using Kaplan-Meier method with left truncation adjustment to mitigate bias due to the prerequisite for NGS testing). HRs were estimated using Cox regression models with covariates adjustment to estimate risk of death. Results: The analysis included 156 METex14 NSCLC pts: median age 75 yrs, 59% females, 85.3% non-squamous (NSQ), 9% squamous cell carcinoma (SQ), and 64% had history of smoking. A total of 31 pts (20%) had BM before 1L initiation: median age 73 yrs, 61% females, 94% NSQ, 0% SQ, and 71% had history of smoking. Overall, treatment patterns were similar for pts with and without known BM before 1L initiation (Ctx with or without IO, IO monotherapy, and MKi were all used in 1L). Median OS for pts with BM was 8.11 mo (95% CI, 6.0-19.8) and 14.39 mo (11.1-22.1) for pts without BM, corresponding to a 73% increase in risk of death for pts with BM vs pts without BM by univariate analysis (HR 1.73 [95% CI, 1.06-2.82]; P=0.03). Median OS for pts with an NGS report before and on/after 1L initiation was 13.3 mo (8.8-26.2) and 6.8 mo (0.03-19.8), respectively (P=0.45); HR by multivariate analysis was 0.78 (0.45-1.35) when comparing pts with NGS report before vs on/after 1L initiation. Conclusions: Tx patterns in 1L were similar for pts with or without BM at time of 1L initiation; presence of BM prior to 1L was associated with inferior outcomes. Numerically longer OS was observed in pts with NGS report prior to 1L initiation vs pts with NGS report on/after 1L, supporting further investigation of underlying causes. These data underline the ongoing unmet clinical need of METex14 NSCLC BM and the importance of investigating upfront comprehensive genomic testing in NSCLC. Citation Format: Xiuning Le, Stephen Robb, Nydia Caro, Simona Doria, Whitney C. Rhodes, Wen-Hsing Wu, Julia Kim, Vincent Prêtre, Fen Ye. Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 4118.
- 6 January 2022
- Published by Springer Nature in Journal of Materials Science: Materials in Electronics
- Vol. 33 (7) , 4497-4509
The effect of B-site acceptor doping on the microstructure and electric properties of NaNbO3 ceramics
- 6 January 2022
- Published by Springer Nature in Journal of Materials Science: Materials in Electronics
- Vol. 33 (7) , 4497-4509
The effect of B-site acceptor doping on the microstructure and electric properties of NaNbO3 ceramics
- 1 January 2022
- Published by Shanghai Institute of Ceramics in Journal of Inorganic Materials
- Vol. 37 (5) , 499-506
Dielectric and Energy Storage Property of (0.96NaNbO3-0.04CaZrO3)-xFe2O3 Antiferroelectric Ceramics
- 1 January 2022
- Published by Shanghai Institute of Ceramics in Journal of Inorganic Materials
- Vol. 37 (5) , 499-506
Dielectric and Energy Storage Property of (0.96NaNbO3-0.04CaZrO3)-xFe2O3 Antiferroelectric Ceramics
- Open Access
- 1 November 2021
- Published by Elsevier in Journal of Materials Research and Technology
- Vol. 15, 5833-5840
High sintering activity NaNbO3 powder synthesis via the polyacrylamide gel method and fabrication of a NaNbO3 ceramic at lower temperature
- 1 November 2021
- Published by Elsevier in Journal of Materials Research and Technology
- Vol. 15, 5833-5840
Open AccessHigh sintering activity NaNbO3 powder synthesis via the polyacrylamide gel method and fabrication of a NaNbO3 ceramic at lower temperature
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 17 (5) , 1217-1233
3,3'-Diindolylmethane induces gastric cancer cells death via STIM1 mediated store-operated calcium entry
3,3'-Diindolylmethane (DIM), a natural phytochemicals isolated from cruciferous vegetables, has been reported to inhibit human gastric cancer cells proliferation and induce cells apoptosis as well as autophagy, but its mechanisms are still unclear. Store-operated calcium entry (SOCE) is a main Ca2+ influx pathway in various of cancers, which is activated by the depletion of endoplasmic reticulum (ER) Ca2+ store. Stromal interaction molecular 1 (STIM1) is the necessary component of SOCE. In this study, we focus on to examine the regulatory mechanism of SOCE on DIM-induced death in gastric cancer. After treating the human BGC-823 and SGC-7901 gastric cancer cells with DIM, cellular proliferation was determined by MTT, apoptosis and autophagy were detected by flow cytometry or Hoechst 33342 staining. The expression levels of related proteins were evaluated by Western blotting. Free cytosolilc Ca2+ level was assessed by fluorescence monitoring under a laser scanning confocal microscope. The data have shown that DIM could significantly inhibit proliferation and induce apoptosis as well as autophagy in two gastric cancer cell lines. After DIM treatment, the STIM1-mediated SOCE was activated by upregulating STIM1 and decreasing ER Ca2+ level. Knockdown STIM1 with siRNA or pharmacological inhibition of SOCE attenuated DIM induced apoptosis and autophagy by inhibiting p-AMPK mediated ER stress pathway. Our data highlighted that the potential of SOCE as a promising target for treating cancers. Developing effective and selective activators targeting STIM1-mediated SOCE pathway will facilitate better therapeutic sensitivity of phytochemicals acting on SOCE in gastric cancer. Moreover, more research should be performed to validate the efficacy of combination chemotherapy of anti-cancer drugs targeting SOCE for clinical application.
- 1 January 2021
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 17 (5) , 1217-1233
Open Access3,3'-Diindolylmethane induces gastric cancer cells death via STIM1 mediated store-operated calcium entry
3,3'-Diindolylmethane (DIM), a natural phytochemicals isolated from cruciferous vegetables, has been reported to inhibit human gastric cancer cells proliferation and induce cells apoptosis as well as autophagy, but its mechanisms are still unclear. Store-operated calcium entry (SOCE) is a main Ca2+ influx pathway in various of cancers, which is activated by the depletion of endoplasmic reticulum (ER) Ca2+ store. Stromal interaction molecular 1 (STIM1) is the necessary component of SOCE. In this study, we focus on to examine the regulatory mechanism of SOCE on DIM-induced death in gastric cancer. After treating the human BGC-823 and SGC-7901 gastric cancer cells with DIM, cellular proliferation was determined by MTT, apoptosis and autophagy were detected by flow cytometry or Hoechst 33342 staining. The expression levels of related proteins were evaluated by Western blotting. Free cytosolilc Ca2+ level was assessed by fluorescence monitoring under a laser scanning confocal microscope. The data have shown that DIM could significantly inhibit proliferation and induce apoptosis as well as autophagy in two gastric cancer cell lines. After DIM treatment, the STIM1-mediated SOCE was activated by upregulating STIM1 and decreasing ER Ca2+ level. Knockdown STIM1 with siRNA or pharmacological inhibition of SOCE attenuated DIM induced apoptosis and autophagy by inhibiting p-AMPK mediated ER stress pathway. Our data highlighted that the potential of SOCE as a promising target for treating cancers. Developing effective and selective activators targeting STIM1-mediated SOCE pathway will facilitate better therapeutic sensitivity of phytochemicals acting on SOCE in gastric cancer. Moreover, more research should be performed to validate the efficacy of combination chemotherapy of anti-cancer drugs targeting SOCE for clinical application.
- 22 October 2018
- Published by Wiley in International Journal of Applied Ceramic Technology
- Vol. 16 (2) , 772-780
In situ synthesis and thermal shock resistance of a cordierite‐mullite composite for solar thermal storage
Cordierite‐mullite composite ceramic was synthesized in situ by semidry pressing and pressureless sintering from andalusite, kaolin, γ‐Al 2 O 3 , talc, potassium feldspar, and albite in air. The effects of composition and sintering temperature on the density, bending strength, thermal shock stability, crystal phases, and microstructure of the specimens were studied. The results show that specimen B2 (the theoretical content of cordierite was 20 wt%) has excellent performance, that is, a bending strength of 104.59 MPa, 30 cycles of thermal shock resistance without cracking, and a loss rate of 13.12%. X‐ray diffractometer ( XRD ) analysis and scanning electron microscope ( SEM ) micrographs showed that spherical cordierite crystals were grown on the surface of the mullite, therefore, the specimen possessed a superior bending strength and thermal shock resistance, where a great number of granules combined to restrain crack initiation as well as propagation over time during the thermal shock test. The thermal conductivity of specimen B2 was determined to be 3.83 W/(m·K) (36°C), and the sensible heat storage density was 1136 kJ/kg, with the temperature difference (Δ T ) ranging from 0 to 800°C. Consequently, the cordierite‐mullite composite is a potentially applicable material for solar thermal storage.
- 22 October 2018
- Published by Wiley in International Journal of Applied Ceramic Technology
- Vol. 16 (2) , 772-780
In situ synthesis and thermal shock resistance of a cordierite‐mullite composite for solar thermal storage
Cordierite‐mullite composite ceramic was synthesized in situ by semidry pressing and pressureless sintering from andalusite, kaolin, γ‐Al 2 O 3 , talc, potassium feldspar, and albite in air. The effects of composition and sintering temperature on the density, bending strength, thermal shock stability, crystal phases, and microstructure of the specimens were studied. The results show that specimen B2 (the theoretical content of cordierite was 20 wt%) has excellent performance, that is, a bending strength of 104.59 MPa, 30 cycles of thermal shock resistance without cracking, and a loss rate of 13.12%. X‐ray diffractometer ( XRD ) analysis and scanning electron microscope ( SEM ) micrographs showed that spherical cordierite crystals were grown on the surface of the mullite, therefore, the specimen possessed a superior bending strength and thermal shock resistance, where a great number of granules combined to restrain crack initiation as well as propagation over time during the thermal shock test. The thermal conductivity of specimen B2 was determined to be 3.83 W/(m·K) (36°C), and the sensible heat storage density was 1136 kJ/kg, with the temperature difference (Δ T ) ranging from 0 to 800°C. Consequently, the cordierite‐mullite composite is a potentially applicable material for solar thermal storage.
- 1 September 2018
- Published by Elsevier in Endocrine Practice
- Vol. 24 (9) , 805-814
Predictors and Clinical Outcomes of Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting
- 1 September 2018
- Published by Elsevier in Endocrine Practice
- Vol. 24 (9) , 805-814
Predictors and Clinical Outcomes of Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting